GC Corp. (KRX:005250)
South Korea · Delayed Price · Currency is KRW 9,530.00
-90.00 (-0.94%)
At close: Sep 22, 2026
GC Corp. Market Cap
GC Corp. has a market cap or net worth of 437.14 billion as of September 22, 2026. Its market cap has decreased by -42.52% in one year.
Market Cap
437.14B
Enterprise Value
2.89T
Revenue
2.49T
Ranking
n/a
PE Ratio
n/a
Stock Price
9,530.00
ChartMarket Cap Chart
Since January 4, 1993, GC Corp.'s market cap has increased from 52.72B to 437.14B, an increase of 729.14%. That is a compound annual growth rate of 6.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 437.14B | -39.52% |
| Dec 30, 2025 | 722.80B | -8.08% |
| Dec 30, 2024 | 786.36B | 5.93% |
| Dec 28, 2023 | 742.32B | -3.82% |
| Dec 29, 2022 | 771.83B | -37.38% |
| Dec 30, 2021 | 1.23T | -34.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 740.02B |
| Komipharm International | 711.84B |
| Onconic Therapeutics | 674.76B |
| Hyundai Bioscience | 656.22B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |
| AbClon | 390.26B |
| Proteina | 386.78B |